RAPS: FDA Revises Labeling Guidance to Clarify Clinical Pharmacology Recommendation
14.08.2014
A new draft guidance document published by the US Food and Drug Administration (FDA) seeks to help sponsors with the \"clinical pharmacology\" sections that accompany an approved drug\'s labeling.
SciencePharma
